Reports for APOTEX INC

Company Name

APOTEX INC

Totals

Shortage reports

3020

Actual shortage: 234 (8%)
Anticipated shortage: 20 (1%)
Avoided shortage: 9 (0%)
Resolved: 2757 (91%)

Discontinuation Reports

356

To be discontinued: 22 (6%)
Discontinued: 334 (94%)
Reversed: 0 (0%)

Late reports

142 (4%)

Overdue reports

28 (10%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-DEFERASIROX 500MG TABLET FOR SUSPENSION Resolved 2017-08-24 2017-09-22 20281
APO-DEFERASIROX 500MG TABLET FOR SUSPENSION Resolved 2018-01-18 2018-02-12 36432
APO-DEFERASIROX 250MG TABLET FOR SUSPENSION Resolved 2018-03-13 2018-07-03 42717
APO-DEFERASIROX 250MG TABLET FOR SUSPENSION Resolved 2020-04-13 2020-05-22 111901
APO-DEFERASIROX 500MG TABLET FOR SUSPENSION Resolved 2020-05-08 2020-05-22 114285
APO-DEFERASIROX 500MG TABLET FOR SUSPENSION Resolved 2020-06-04 2020-07-28 116533
APO-DEFERASIROX 250MG TABLET FOR SUSPENSION Resolved 2020-08-06 2020-11-28 121891
APO-DEFERASIROX 250MG TABLET FOR SUSPENSION Resolved 2023-09-07 2023-09-15 203819
APO-ZOLPIDEM ODT 5MG TABLET (ORALLY DISINTEGRATING) Resolved 2017-03-10 2017-04-10 245
APO-ZOLPIDEM ODT 10MG TABLET (ORALLY DISINTEGRATING) Resolved 2017-03-10 2017-04-17 249
APO-RIZATRIPTAN RPD 10MG TABLET (ORALLY DISINTEGRATING) Resolved 2017-03-11 2020-07-06 490
APO-RIZATRIPTAN RPD 5MG TABLET (ORALLY DISINTEGRATING) Resolved 2017-03-11 2018-09-11 493
APO-OLANZAPINE ODT 20MG TABLET (ORALLY DISINTEGRATING) Resolved 2017-06-13 2017-07-31 12689
APO-OLANZAPINE ODT 15MG TABLET (ORALLY DISINTEGRATING) Resolved 2017-08-08 2017-08-23 18546
APO-OLANZAPINE ODT 20MG TABLET (ORALLY DISINTEGRATING) Resolved 2017-10-03 2018-01-29 24277
APO-ZOLMITRIPTAN RAPID 2.5MG TABLET (ORALLY DISINTEGRATING) Resolved 2017-10-12 2018-09-12 25649
APO-OLANZAPINE ODT 10MG TABLET (ORALLY DISINTEGRATING) Resolved 2017-11-13 2018-08-15 29036
APO-OLANZAPINE ODT 15MG TABLET (ORALLY DISINTEGRATING) Resolved 2017-11-15 2018-01-31 29348
APO-OLANZAPINE ODT 15MG TABLET (ORALLY DISINTEGRATING) Resolved 2018-04-02 2018-09-04 44507
APO-OLANZAPINE ODT 5MG TABLET (ORALLY DISINTEGRATING) Resolved 2018-04-02 2018-08-15 44510

Showing 1 to 20 of 3020

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO GLYBURIDE TAB 5MG 5MG TABLET Discontinued 2018-09-07 2018-12-14 60518
APO-HYDROCHLOROTHIAZIDE 50MG TABLET Discontinued 2018-09-07 2019-02-13 60521
APO-HYDROXYQUINE 200MG TABLET Discontinued 2018-09-07 2018-10-05 60524
APO-IBUPROFEN 300MG TABLET Discontinued 2018-09-07 2018-09-15 60527
APO-IBUPROFEN 400MG TABLET Discontinued 2018-09-07 2018-09-15 60530
APO-IRBESARTAN 150MG TABLET Discontinued 2018-09-07 2018-12-28 60536
APO-IRBESARTAN 300MG TABLET Discontinued 2018-09-07 2018-09-15 60539
APO-LAMIVUDINE 150MG TABLET Discontinued 2018-09-07 2019-07-13 60557
APO-LAMIVUDINE 300MG TABLET Discontinued 2018-09-07 2019-07-13 60560
APO-LAMIVUDINE HBV 100MG TABLET Discontinued 2018-09-07 2019-12-21 60563
APO-LEVOCARB - TAB 25MG/250MG 25MG 250MG TABLET Discontinued 2018-09-07 2019-02-07 60576
APO-LISINOPRIL 10MG TABLET Discontinued 2018-09-07 2019-02-02 60579
APO-LISINOPRIL 20MG TABLET Discontinued 2018-09-07 2018-11-26 60582
APO-LISINOPRIL 5MG TABLET Discontinued 2018-09-07 2019-02-13 60585
APO-LORAZEPAM 0.5MG TABLET Discontinued 2018-09-07 2018-12-28 60591
APO-LORAZEPAM 1MG TABLET Discontinued 2018-09-07 2018-10-05 60594
APO-LOSARTAN/HCTZ 12.5MG 100MG TABLET Discontinued 2018-09-07 2018-11-02 60597
APO-LOSARTAN/HCTZ 25MG 100MG TABLET Discontinued 2018-09-07 2018-12-28 60600
APO-LOSARTAN/HCTZ 12.5MG 50MG TABLET Discontinued 2018-09-07 2018-12-28 60603
APO-MEDROXY TABLETS 2.5MG TABLET Discontinued 2018-09-07 2018-09-15 60609

Showing 121 to 140 of 356